PROLOG Study - AMSL Diabetes


PROLOG Study

The PROLOG study evaluates the predictive low glucose suspend algorithm (PLGS), Basal-IQ™ technology.

Stay informed with AMSL Diabetes

Now you can get all the latest news and updates of our products, events and resources right into your inbox.

Something went wrong. Please try again later!

Back to top